Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Jones, M.D.
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
70 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Antwerp, Belgium
- Facility name not stated
Bruges, Belgium
- Facility name not stated
Aachen, Germany
- Facility name not stated
Berlin, Germany
- Facility name not stated
Freiburg im Breisgau, Germany
- Facility name not stated
Hamburg, Germany
- Facility name not stated
Stuttgart, Germany
- Facility name not stated
Ulm, Germany
- Facility name not stated
Galway, Ireland
- Facility name not stated
Florence, Italy
- Facility name not stated
Reggio Calabria, Italy
- Facility name not stated
Varese, Italy
- Facility name not stated
Barcelona, Spain
- Facility name not stated
Pamplona, Spain
- Facility name not stated
Salamanca, Spain
- Facility name not stated
Boston, United Kingdom
- Facility name not stated
Leicester, United Kingdom
- Facility name not stated
Nottingham, United Kingdom
- Facility name not stated
West Bromwich, United Kingdom
- Facility name not stated
Scottsdale, Arizona, United States
- Facility name not stated
Fayetteville, Arkansas, United States
- Facility name not stated
Burbank, California, United States
- Facility name not stated
Glendale, California, United States
- Facility name not stated
La Jolla, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
Aurora, Colorado, United States
- Facility name not stated
Stamford, Connecticut, United States
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Boynton Beach, Florida, United States
- Facility name not stated
Orlando, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Niles, Illinois, United States
- Facility name not stated
Springfield, Illinois, United States
- Facility name not stated
Ames, Iowa, United States
- Facility name not stated
Westwood, Kansas, United States
- Facility name not stated
Alexandria, Louisiana, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Southfield, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2012
- Primary completion
- 31 Mar 2014
- Completion
- 31 May 2016
- Last update posted
- 14 Nov 2017
- Registered enrollment
- 110
- Registry id
- NCT01632904
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.